A short interview with Jeff Davis, CEO of Access Pharmaceuticals (OTCBB: ACCP) by Tom Allinder of ProActiveNewsRoom.com. A discussion of recent results regarding one of the Company's flagship products, MuGard.
Instead of creating products that offset the side effects of chemo which has proven not to work-this is just another pharma product-to prolong diseases.
Chemo is primitive medicine-and should be abandoned completely -it is ancient medicine that kills healthy cells and does nothing to prevent cancer or cure it.
This is just another money maker for the drug company-bad science in the wrong direction.
Instead of creating products that offset the side effects of chemo which has proven not to work-this is just another pharma product-to prolong diseases.
Chemo is primitive medicine-and should be abandoned completely -it is ancient medicine that kills healthy cells and does nothing to prevent cancer or cure it.
This is just another money maker for the drug company-bad science in the wrong direction.
12dogpal 2 years ago